Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through toll-like receptor-4

2011 Nobel Prize in Physiology or Medicine

(2011) Alain Tedgui et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Advances in tenascin-C biology

(2011) Kim S. Midwood et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Scavenger receptors: Implications in atherothrombotic disorders

(2011) Mohammad Z. Ashraf et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Toll-like Receptor 4 Mediates Oxidized LDL-Induced Macrophage Differentiation to Foam Cells

(2011) Kenneth W. Howell et al.   JOURNAL OF SURGICAL RESEARCH

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets

(2011) Charlotte Lahoute et al.   Nature Reviews Cardiology

Lipopolysaccharide up-regulates the expression of Fcα/μ receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages

(2009) Xuyang Feng et al.   ATHEROSCLEROSIS

Adaptive immunity and atherosclerosis

(2009) John Andersson et al.   CLINICAL IMMUNOLOGY

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

(2009) Cameron R Stewart et al.   NATURE IMMUNOLOGY

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

(2009) Kim Midwood et al.   NATURE MEDICINE

Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis

(2008) Yasushi Ishigaki et al.   CIRCULATION

Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells

(2008) L. Jiang et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY